Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
A Clinical Study of Intratumoral MVR-T3011 (T3011) Given as a Single Agent and in Combination With Intravenous Pembrolizumab in Participants With Advanced or Metastatic Solid TumorsHead and Neck Neoplasms, Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Connective and Soft Tissue, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Skin and Connective Tissue Diseases, carcinoma, epithelial neoplasm, head and neck squamous cell carcinoma, melanocytic neoplasm, melanoma, neoplasm, neuroendocrine neoplasm, non-small cell lung carcinoma, primitive neuroectodermal tumor, sarcoma, skin disorder, skin neoplasm, squamous cell carcinoma, squamous cell neoplasmRecruitingPhase 1 / Phase 22025-10-08NCT04370587

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
ImmVira Pharma Co. Ltd3

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Banner Md Anderson Cancer CenterGilbertUnited States121
Dana Farber Cancer InstituteBostonUnited States300
Mary Crowley Cancer ResearchDallasUnited States29
Massachusetts General HospitalBostonUnited States1015
Peninsula & South Eastern Haematology and Oncology GroupFrankstonAustralia1
Southern OncologyBedford ParkAustralia1
The AlfredMelbourneAustralia1
University of Pittsburgh Medical CenterPittsburghUnited States63
Virginia Cancer SpecialistsFairfaxUnited States109